- From Big Pharma to specialty: why moving closer to the patient changes everythingWorking at a Big Pharma has its benefits, but there are limitations too. SERB Pharmaceuticals’ Thomas Kolaras discusses how moving to a midsize company creates new opportunities for sharpened think…BioSpace · 5d ago↗ source
- AI data becomes sticking point in biopharma dealmakingAs drug hunting gets more complex, where and how data is generated in partnerships between Big Pharmas and AI biotechs is becoming a headache for dealmakers.BioSpace · 5d ago↗ source
- STAT+: More workers hate their jobs, but keep them for the health insuranceA new survey reveals 24% of U.S. workers stay in unwanted jobs to keep health insurance. Experts call it 'job lock.'STAT